Review
Accepted on 04 Dec 2025
Liquid Biopsy in Biliary Tract Cancers: Early Diagnosis, Precision Therapy, and Prognostic Evaluation
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
Type at least 3 characters
1,057 articles
Case Report
Published on 04 Dec 2025
Efficacy of lenvatinib combined with TAS-102 as second-line therapy for advanced intrahepatic cholangiocarcinoma: a case report
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1695911
- 189 views
Mini Review
Published on 03 Dec 2025
Complementary strategies in pancreatic cancer precision medicine: therapeutic prediction and immune modulation
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1718911
- 257 views
Case Report
Accepted on 02 Dec 2025
Adult UESL mimicking a simple hepatic cyst and initially misdiagnosed as a benign lesion
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
- 109 views
Original Research
Published on 02 Dec 2025
Clinical efficacy of hepatic arterial infusion chemotherapy combined with transhepatic arterial embolization plus lenvatinib and tislelizumab or transarterial chemoembolization combined with lenvatinib plus tislelizumab in the treatment of advanced hepatocellular carcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1665348
- 450 views
Case Report
Published on 02 Dec 2025
Histotripsy for portal vein tumor thrombus in a patient with hepatocellular carcinoma: a case report
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1721814
- 415 views
Original Research
Accepted on 30 Nov 2025
Preoperative Predictors of Unplanned Conversion in Laparoscopic Liver Resection: A Multicenter Cohort Analysis
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
Original Research
Accepted on 29 Nov 2025
A Radiomic Model for Non-Invasive Prediction of PD-L1 and VETC Expression in Hepatocellular Carcinoma Using Enhanced Abdominal CT
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
Case Report
Accepted on 29 Nov 2025
Primary Hepatic Osteosarcoma: A case report and literature review
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
Methods
Accepted on 28 Nov 2025
Ablatio-bilica: Safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract cancer undergoing systemic -anti-tumor therapy: a phase II, multi-center, randomized, and controlled study
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
Review
Accepted on 28 Nov 2025
Explainable Artificial Intelligence (XAI) in Pancreatic Cancer Prediction: From Transparency to Clinical Decision-Making
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
- 112 views
Original Research
Accepted on 27 Nov 2025
Transarterial chemoembolization with rivoceranib and camrelizumab for BCLC stage C hepatocellular carcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
- 157 views
Original Research
Accepted on 26 Nov 2025
A CT-Based Interpretable Machine Learning Model for Preoperative Prediction of Pancreatic Neuroendocrine Tumor Aggressiveness
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
Case Report
Published on 26 Nov 2025
Case Report: A case of intrahepatic papillary neoplasm of the bile duct with invasive carcinoma in a young patient and review of the literature
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1670234
- 222 views
Original Research
Published on 26 Nov 2025
Right-side versus left-side hemihepatectomy for the treatment of Bismuth type IV perihilar cholangiocarcinoma: a comparative study
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1663334
- 355 views
Systematic Review
Accepted on 25 Nov 2025
Efficacy of TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of patients with unresectable hepatocellular carcinoma: A systematic review and Meta-analysis
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
- 133 views